Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.

Ms. Jianying  Zhuang

Head of Accounting Department

Jianing  Liu

Chief Investment Officer & Head of BD Dept.

Mr. Jun  Du

Vice President

Mr. Liang  Yang

Vice President, Secretary to the Board & Company Secretary

Ms. Yuxuan  Huang

Mr. Maolin  Wang

Chief Supervisor and GM of Legal & Compliance

Mr. Yanggang  Tang

President & Executive Director

Mr. Guoxiang  Xu

Executive Vice Chairman & Vice President of Sales

Ms. Yanxia  Si

Vice President & Chief Financial Officer

Mr. Daihong  Yang

Livzon Pharmaceutical Group Inc.

Livzon Pharmaceutical Group Inc. 経営体制

経営情報